Characteristics and thrombogenicity of factor IX concentrate.
Thrombogenicity of the factor IX concentrate and its clinical use for stoppage of the bleeding in the case of hemophilia A with inhibitor were reported. (1) Factor IX concentrate contained the coagulation factors as prothrombin complex (factors II, VII, IX and X); Thrombin and factor Xa. (2) Prothrombin in the factor IX concentrate could be converted to thrombin without any additional procoagulant such as thromboplastin or factor V, but in just 2.5M glycine solution by the effect of factor Xa. (3) The infusion of factor IX concentrate into a rabbit induced DIC promptly which was proved by autopsy and coagulation-fibrinolytic studies. (4) Factor IX concentrate showed a great efficacy in stopping the bleeding in the case of hemophilia A with inhibitor.
D000328:Adult; D000818:Animals; D001777:Blood Coagulation; D005164:Factor IX / Q000627:therapeutic use; D006467:Hemophilia A / Q000097:blood / Q000628:therapy; D006801:Humans; D008297:Male; D011817:Rabbits
D005164:Factor IX